12 articles
Federal health officials plan to update testosterone therapy labels, dropping most prostate cancer restrictions after a 5,200-man trial found no added.
Young men are turning to unproven "spermmaxxing" trends like testicle tanning despite sperm counts dropping 50% in recent decades.
Men with low testosterone face higher risks of heart disease, diabetes, and depression, prompting experts to recommend annual screening after 40.
UK targets prostate cancer screening to men aged 45-61 with BRCA2 gene mutations and family cancer history, aiming to catch aggressive tumors early.
Men avoid routine medical visits far more than women, causing heart disease and cancer to be diagnosed late when treatment becomes harder.
A new survey reveals 43% of Australian men experienced poor mental health in the past year, yet many bottle up their feelings.
One in four Singaporean men have low testosterone but don't know it, mistaking fatigue and low libido for normal aging when treatment is available.
Prostate cancer screening with PSA tests remains deeply controversial among medical experts.
Over 70% of men over 40 experience andropause symptoms like fatigue and erectile dysfunction.
Advanced prostate cancer diagnoses have surged 6% yearly since 2012, even as overall cases decline.
New machine learning models can predict clinically significant prostate cancer with up to 88% accuracy using PSA levels and MRI scans, potentially sparing...
Researchers at OHSU received $9.2 million to develop miniature human tissue models that mimic how prostate cancer spreads to bone.
